Abstract
RGD peptides, radiolabeled with 18F, have been used in the clinic for PET imaging of tumor angiogenesis in cancer patients. RGD peptides are typically labeled using a prosthetic group such as N-succinimidyl 4-[18F]-fluorobenzoate ([18F]SFB) or 4-nitrophenyl 2-[18F]-fluoropropionate ([18F]NPFP). However, the complex radiosynthetic procedures have impeded their broad application in clinical studies. We previously radiolabeled proteins and peptides with the prosthetic group, N-succinimidyl 4-[18F]-fluoromethylbenzoate ([18F]SFMB), which was prepared in a simple one-step procedure. In this study, we labeled a PEGylated cyclic RGD peptide dimer, PEG3-E[c(RGDyK)]2 (PRGD2), using [18F]SFMB and evaluated for imaging tumor αvβ3 integrin expression with positron emission tomography (PET). [18F]SFMB was prepared in one step using [18F]fluoride displacement of a nitrobenzenesulfonate leaving group under mild reaction conditions followed by HPLC purification. The 18F-labeled peptide, [18F]FMBPRGD2 was prepared by coupling PRGD2 with [18F]SFMB in pH 8.6 borate buffer and purified with HPLC. The direct labeling on BMBPRGD2 was also attempted. A Siemens Inveon PET was used to image the uptake of the [18F]FMBPRGD2 into a U87MG xenograft mouse model. [18F]FMBPRGD2, was prepared with a 15% overall radiochemical yield (uncorrected) in a total synthesis time of 90 min, which was considerably shorter than the preparation of [18F]SFB- and [18F]NPFP-labeled RGD peptides. The direct labeling, however, was not successful. High quality microPET images using [18F]FMBPRGD2 clearly visualized tumors by 15 min with good target to background ratio. Early tracer accumulation in the bladder suggests fast renal clearance. No obvious bone uptake can be detected even at 4-h time point indicating that fluorine attachment is stable in mice. In conclusion, N-succinimidyl 4-[18F]-fluoromethylbenzoate ([18F]SFMB) prosthetic group can be a good alternative for labeling RGD peptides to image αvβ3 integrin expression and for labeling other peptides.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bading JR, Horling M, Williams LE, Colcher D, Raubitschek A, Strand SE (2008) Quantitative serial imaging of an 124I anti-CEA monoclonal antibody in tumor-bearing mice. Cancer Biother Radiopharm 23(4):399–409
Cai W, Zhang X, Wu Y, Chen X (2006) A thiol-reactive 18F-labeling agent, N-[2-(4–18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of αvβ3 integrin expression. J Nucl Med 47:1172–1180
Chin FT, Shen B, Liu S, Berganos RA, Chang E, Mittra E, Chen X, Gambhir SS (2011) First experience with clinical-grade [18F]FPP(RGD)2: an automated multi-step radiosynthesis for clinical PET studies. Mol Imaging Biol. doi:10.1007/s11307-011-0477-3
Gao H, Niu G, Yang M, Quan Q, Ma Y, Murage E, Ahn JM, Kiesewetter D, Chen X (2011) PET of insulinoma using 18F-FBEM-EM3106b, a new GLP-1 analog. Mol Pharm. 8:1669–1676
Jacobson O, Chen X (2010) PET designated flouride-18 production and chemistry. Curr Top Med Chem 10:1048–1059
Jacobson O, Zhu L, Ma Y, Weiss ID, Sun X, Niu G, Kiesewetter DO, Chen X (2011) Rapid and simple one-step F-18 labeling of peptides. Bioconjug Chem 22:422–428
Kiesewetter DO, Jacobson O, Lang L, Chen X (2011) Automated radiochemical synthesis of [18F]FBEM: A thiol reactive synthon for radiofluorination of peptides and proteins. Appl Radiat Isot 69:410–414
Lang L, Eckelman WC (1994) One-step synthesis of 18F-labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling. Appl Radiat Isot 45:1155–1163
Lang L, Eckelman WC (1997) Labeling proteins at high specific activity using N-succinimidyl 4-[18F](fluoromethyl)benzoate. Appl Radiat Isot 48:169–173
Li ZB, Wu Z, Chen K, Ryu EK, Chen X (2008) 18F-labeled BBN-RGD heterodimer for prostate cancer imaging. J Nucl Med 49(3):453–461
Liu S, Liu Z, Chen K, Yan Y, Watzlowik P, Wester HJ, Chin FT, Chen X (2010) 18F-labeled galacto and pegylated RGD dimers for PET imaging of αvβ3 integrin expression. Mol Imaging Biol 12:530–538
McBride WJ, Sharkey RM, Karacay H, D’Souza CA, Rossi EA, Laverman P, Chang CH, Boerman OC, Goldenberg DM (2009) A novel method of 18F radiolabeling for PET. J Nucl Med 50:991–998
McBride WJ, D’Souza CA, Sharkey RM, Karacay H, Rossi EA, Chang CH, Goldenberg DM (2010) Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem 21(7):1331–1340
Mittra ES, Goris ML, Iagaru AH, Kardan A, Burton L, Berganos R, Chang E, Liu S, Shen B, Chin FT, Chen X, Gambhir SS (2011) Pilot pharmacokinetic and dosimetric studies of 18F-FPPRGD2: a PET radiopharmaceutical agent for imaging αvβ3 integrin levels. Radiology. 260:182–191
Wu Z, Li ZB, Cai W, He L, Chin FT, Li F, Chen X (2007) 18F-labeled mini-peg spacered RGD dimer (18F-FPRGD2): Synthesis and microPET imaging of αvβ3 integrin expression. Eur J Nucl Med Mol Imaging 34:1823–1831
Yang M, Gao H, Yan Y, Sun X, Chen K, Quan Q, Lang L, Kiesewetter D, Niu G, Chen X (2011a) PET imaging of early response to the tyrosine kinase inhibitor ZD4190. Eur J Nucl Med Mol Imag 38(7):1237–1247
Yang M, Gao H, Zhou Y, Ma Y, Quan Q, Lang L, Chen K, Niu G, Yan Y, Chen X (2011b) 18F-labeled GRPR agonists and antagonists: a comparative study in prostate cancer imaging. Theranostics 1:220–229
Zhang X, Xiong Z, Wu Y, Cai W, Tseng JR, Gambhir SS, Chen X (2006) Quantitative PET imaging of tumor integrin αvβ3 expression with 18F-FRGD2. J Nucl Med 47:113–121
Acknowledgments
This work was supported by the intramural programs of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, the International Cooperative Program of the National Science Foundation of China (NSFC) (81028009), and the International Cooperation Project of the Chinese Ministry of Science and Technology (2009DFB30040).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, W., Lang, L., Niu, G. et al. N-Succinimidyl 4-[18F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression. Amino Acids 43, 1349–1357 (2012). https://doi.org/10.1007/s00726-011-1208-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-011-1208-4